On International NASH Day 2023, join Michael Betel of the Fatty Liver Alliance as he addresses NAFLD and NASH, their prevalence and impact. Discover solutions including medical education, patient awareness, and advocacy. Learn about the Alliance's future goals.View More ⏩Building a Better Future For Patients with NAFLD and NASH
Prof. Stéfan Darmoni, France, discusses the clinical data warehouses (CDW) where he explains its definitions and various use cases.View More ⏩Clinical Data Warehouse : definitions and use cases
2020 started with an important discussion about the terminology to be used regarding Non Alcoholic Fatty Liver Disease (NAFLD). In this exclusive interview for the PanNASH web site, Prof Sven Francque discusses the rationale of this change and the possible impact in clinical practiceView More ⏩NAFLD: time to update the terminology? By Prof. S. Francque
In this Expert perspective video, Prof Sven Francque explains how to make the distinction between NAFL and NASH. This is important even though in clinical practice there is a continuum between the two. In the pathophysiology of NASH there is a complex interplay between different organs. Adipose tissue dysfunction is an important driver of disease.View More ⏩NAFLD: a hegemonic disease by Prof. S. Francque
View More ⏩What are the current definitions ? Prof Abdelmalek, USA
So NAFLD (non-alcoholic fatty liver disease) is a…
Prof Jean-François Dufour, Switzerland sheds lights on this important question.View More ⏩Is NASH only about the liver ?